Lexicon Pharmaceuticals
LXRX
#6852
Rank
โ‚ฌ0.62 B
Marketcap
1,40ย โ‚ฌ
Share price
-7.76%
Change (1 day)
11.71%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -โ‚ฌ52.85 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ41.46 Million. In 2025 the company made an earning of -โ‚ฌ45.89 Million, an increase over its 2024 earnings that were of -โ‚ฌ0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ52.85 Million15.17%
2025 -โ‚ฌ45.89 Million-74.88%
2024 -โ‚ฌ0.19 Billion13.15%
2023 -โ‚ฌ0.17 Billion73.74%
2022 -โ‚ฌ92.92 Million16.16%
2021 -โ‚ฌ79.99 Million49.82%
2020 -โ‚ฌ53.39 Million-147.19%
2019 โ‚ฌ0.11 B-203.42%
2018 -โ‚ฌ0.11 Billion-15.31%
2017 -โ‚ฌ0.13 Billion0.2%
2016 -โ‚ฌ0.13 Billion2920.7%
2015 -โ‚ฌ4.27 Million-95.33%
2014 -โ‚ฌ91.48 Million-3.61%
2013 -โ‚ฌ94.91 Million-5.52%
2012 -โ‚ฌ0.11 Billion-4.17%
2011 -โ‚ฌ0.11 Billion15.5%
2010 -โ‚ฌ90.76 Million8.36%
2009 -โ‚ฌ83.76 Million-4.81%
2008 -โ‚ฌ87.99 Million28.79%
2007 -โ‚ฌ68.32 Million35.71%
2006 -โ‚ฌ50.34 Million52.91%
2005 -โ‚ฌ32.92 Million-23.89%
2004 -โ‚ฌ43.25 Million-24.19%
2003 -โ‚ฌ57.05 Million-0.48%
2002 -โ‚ฌ57.33 Million44.12%
2001 -โ‚ฌ39.78 Million23.01%
2000 -โ‚ฌ32.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
โ‚ฌ7.19 B-13,024.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ1.01 B-1,927.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ5.18 B-9,404.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.41 Billion 631.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ55.51 M-199.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚ฌ72.35 M-229.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚ฌ21.19 Million-61.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ39.79 M-171.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚ฌ15.06 Million-72.97%๐Ÿ‡บ๐Ÿ‡ธ USA